[go: up one dir, main page]

WO1996003436A3 - Gamma-interferon d'origine equine - Google Patents

Gamma-interferon d'origine equine Download PDF

Info

Publication number
WO1996003436A3
WO1996003436A3 PCT/GB1995/001732 GB9501732W WO9603436A3 WO 1996003436 A3 WO1996003436 A3 WO 1996003436A3 GB 9501732 W GB9501732 W GB 9501732W WO 9603436 A3 WO9603436 A3 WO 9603436A3
Authority
WO
WIPO (PCT)
Prior art keywords
interferon
equine
recombinant
polynucleotide fragment
recombinant vector
Prior art date
Application number
PCT/GB1995/001732
Other languages
English (en)
Other versions
WO1996003436A2 (fr
Inventor
David Edward Onions
Lesley Nicholson
Original Assignee
Q One Biotech Ltd
David Edward Onions
Lesley Nicholson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Q One Biotech Ltd, David Edward Onions, Lesley Nicholson filed Critical Q One Biotech Ltd
Priority to AU30832/95A priority Critical patent/AU3083295A/en
Publication of WO1996003436A2 publication Critical patent/WO1996003436A2/fr
Publication of WO1996003436A3 publication Critical patent/WO1996003436A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Cette invention concerne un fragment polynucléotidique codant un gamma-interféron d'origine équine, un vecteur de recombinaison comprenant un fragment polynucléotidique de ce type, une cellule hôte contenant ledit fragment polynucléotidique ou ledit vecteur de recombinaison, un polypeptide de gamma-interféron d'origine équine obtenu par recombinaison, et des compositions pharmaceutiques comprenant le gamma-interféron de recombinaison utilisé comme agent prophylactique et/on thérapeutique et également comme adjuvant.
PCT/GB1995/001732 1994-07-21 1995-07-21 Gamma-interferon d'origine equine WO1996003436A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU30832/95A AU3083295A (en) 1994-07-21 1995-07-24 Equine gamma-interferon

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9414753.5 1994-07-21
GB9414753A GB2291645A (en) 1994-07-21 1994-07-21 Equine gamma-interferon

Publications (2)

Publication Number Publication Date
WO1996003436A2 WO1996003436A2 (fr) 1996-02-08
WO1996003436A3 true WO1996003436A3 (fr) 1996-10-03

Family

ID=10758695

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1995/001732 WO1996003436A2 (fr) 1994-07-21 1995-07-21 Gamma-interferon d'origine equine

Country Status (3)

Country Link
AU (1) AU3083295A (fr)
GB (1) GB2291645A (fr)
WO (1) WO1996003436A2 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642096A1 (de) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int Pferde-(gamma)-interferon
WO1992003574A1 (fr) * 1990-08-13 1992-03-05 The University Of Melbourne Production de cytokine
WO1992005255A1 (fr) * 1990-09-13 1992-04-02 Commonwealth Scientific And Industrial Research Organisation Genes de cytokine d'origine ovine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642096A1 (de) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int Pferde-(gamma)-interferon
EP0271824A2 (fr) * 1986-12-10 1988-06-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Gamma-Interféron de cheval
WO1992003574A1 (fr) * 1990-08-13 1992-03-05 The University Of Melbourne Production de cytokine
WO1992005255A1 (fr) * 1990-09-13 1992-04-02 Commonwealth Scientific And Industrial Research Organisation Genes de cytokine d'origine ovine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CURRAN J.A. ET AL.: "Nucleotide sequence of the equine interferon gamma cDNA", DNA SEQUENCE, vol. 4, no. 6, pages 405 - 407 *
GRÜNIG G. ET AL.: "Cloning and sequencing of horse interferon-gamma cDNA", IMMUNOGENETICS, vol. 39, no. 6, 28 April 1994 (1994-04-28), pages 448 - 449 *
YILMA T. ET AL.: "Preliminary characterization of equine Interferons and their antiviral activities on bovine, ovine and human cells", J. INTERFERON RES., vol. 2, no. 3, pages 363 - 370 *

Also Published As

Publication number Publication date
AU3083295A (en) 1996-02-22
WO1996003436A2 (fr) 1996-02-08
GB9414753D0 (en) 1994-09-07
GB2291645A (en) 1996-01-31

Similar Documents

Publication Publication Date Title
WO1996017072A3 (fr) Vecteurs d'alphavirus de recombinaison
WO1995007994A3 (fr) Vecteurs composes d'alphavirus recombinants
AUPP051497A0 (en) Antimicrobial peptides
EP1231218A3 (fr) Peptide coupe-faim, ses compositions et son utilisation
EP0962467A4 (fr) Anticorps contre les peptides lies a la parathormone humaine
IL130102A (en) Aminoguanidines and alkoxyguanidines as protease inhibitors, pharmaceutical compositions containing the same and processes for preparing the same
WO2001053312A8 (fr) Nouveaux acides nucleiques et polypeptides
WO2001053455A3 (fr) Nouveaux acides nucleiques et polypeptides associes
AU6743294A (en) Xylanase derived from a bacillus species, expression vectors for such xylanase and other proteins, host organismstherefor and use thereof
WO1999058562A3 (fr) Nouveaux composes
AU8812498A (en) Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
IE830161L (en) Multifunctional cloning vectors
WO1999055873A3 (fr) Polynucleotide(s) et polypeptides basb006 isoles a partir de neisseria meningites
BR0312889A (pt) Polipeptìdeo t20 peguilado
IL143516A (en) E3 ubiquitin ligase polypeptide, polynucleotide encoding the same and uses thereof
WO1996003435A3 (fr) Gamma-interferon d'origine feline
AU6292694A (en) Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof
WO2000058465A3 (fr) Analogues polypeptidiques de flint
GB9820003D0 (en) Novel compounds
WO1996003436A3 (fr) Gamma-interferon d'origine equine
WO1997005251A3 (fr) Cytokine slf feline
GB9809683D0 (en) Novel compounds
WO1999031229A3 (fr) Peptides et acides nucleiques derives d'eisenia foetida et leur utilisation
AU4505099A (en) (moraxella catarrahalis) polynucleotides and polypeptides
AU4504999A (en) Novel compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase